Okeiro offers an AI platform for chronic disease and transplant care, enabling early detection, monitoring, and treatment.
Okeiro has raised $11.1M in total funding. The most recent round was Series A. The last funding was announced in April 2025.
Okeiro's investors include Alven, Forepont Capital Partners, Red River West.
Okeiro is headquartered in Paris, France.
Okeiro offers an AI platform for chronic disease and transplant care, enabling early detection, monitoring, and treatment.
Okeiro is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Okeiro — Funding & Investors." VCBacked, April 10, 2025, https://www.vcbacked.co/company/okeiro. Accessed September 10, 2026.
VCBacked. (2025). Okeiro — Funding & Investors. Retrieved September 10, 2026, from https://www.vcbacked.co/company/okeiro
{{cite web |title=Okeiro — Funding & Investors |url=https://www.vcbacked.co/company/okeiro |website=VCBacked |access-date=September 10, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated